Cargando…
Production of Mucosally Transmissible SHIV Challenge Stocks from HIV-1 Circulating Recombinant Form 01_AE env Sequences
Simian-human immunodeficiency virus (SHIV) challenge stocks are critical for preclinical testing of vaccines, antibodies, and other interventions aimed to prevent HIV-1. A major unmet need for the field has been the lack of a SHIV challenge stock expressing circulating recombinant form 01_AE (CRF01_...
Autores principales: | Tartaglia, Lawrence J., Chang, Hui-Wen, Lee, Benjamin C., Abbink, Peter, Ng’ang’a, David, Boyd, Michael, Lavine, Christy L., Lim, So-Yon, Sanisetty, Srisowmya, Whitney, James B., Seaman, Michael S., Rolland, Morgane, Tovanabutra, Sodsai, Ananworanich, Jintanat, Robb, Merlin L., Kim, Jerome H., Michael, Nelson L., Barouch, Dan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743977/ https://www.ncbi.nlm.nih.gov/pubmed/26849216 http://dx.doi.org/10.1371/journal.ppat.1005431 |
Ejemplares similares
-
Differential Outcomes following Optimization of Simian-Human Immunodeficiency Viruses from Clades AE, B, and C
por: Tartaglia, Lawrence J., et al.
Publicado: (2020) -
HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes
por: Xiao, Tianshu, et al.
Publicado: (2020) -
Therapeutic Efficacy of Potent Neutralizing HIV-1-Specific Monoclonal Antibodies in SHIV-Infected Rhesus Monkeys
por: Barouch, Dan H., et al.
Publicado: (2013) -
Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys
por: Keele, Brandon F., et al.
Publicado: (2017) -
Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge
por: Om, Kier, et al.
Publicado: (2020)